BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pezhouh MK, Miller JA, Sharma R, Borzik D, Eze O, Waters K, Westerhoff MA, Parian AM, Lazarev MG, Voltaggio L. Refractory inflammatory bowel disease: is there a role for Epstein-Barr virus? A case-controlled study using highly sensitive Epstein-Barr virus-encoded small RNA1 in situ hybridization. Hum Pathol 2018;82:187-92. [PMID: 30120969 DOI: 10.1016/j.humpath.2018.08.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Kato S, Shimizu H, Tomii S, Uchida H, Kawamoto A, Hibiya S, Motobayashi M, Takenaka K, Fujii T, Saito E, Nagahori M, Ohtsuka K, Negi M, Akashi T, Matsuyama T, Kinugasa Y, Watanabe M. Substantial Epstein-Barr virus reactivation in a case of severe refractory ulcerative colitis: a possible role in exacerbation. Clin J Gastroenterol 2021;14:584-8. [PMID: 33400186 DOI: 10.1007/s12328-020-01319-w] [Reference Citation Analysis]
2 Tian S, Westbrook LM, Xiao S, Zhang Y, Huang Y, Wang HL. The Morphologic Features of Primary Epstein-Barr Virus Infection in the Gastrointestinal Tract: An Approach to Correct Diagnosis. American Journal of Surgical Pathology 2019;43:1253-63. [DOI: 10.1097/pas.0000000000001319] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
3 Wu S, He C, Tang TY, Li YQ. A review on co-existent Epstein-Barr virus-induced complications in inflammatory bowel disease. Eur J Gastroenterol Hepatol 2019;31:1085-91. [PMID: 31205127 DOI: 10.1097/MEG.0000000000001474] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
4 Xu S, Chen H, Zu X, Hao X, Feng R, Zhang S, Chen B, Zeng Z, Chen M, Ye Z, He Y. Epstein-Barr virus infection in ulcerative colitis: a clinicopathologic study from a Chinese area. Therap Adv Gastroenterol 2020;13:1756284820930124. [PMID: 32913442 DOI: 10.1177/1756284820930124] [Reference Citation Analysis]
5 Zhou JQ, Zeng L, Zhang Q, Wu XY, Zhang ML, Jing XT, Wang YF, Gan HT. Clinical features of Epstein-Barr virus in the intestinal mucosa and blood of patients with inflammatory bowel disease. Saudi J Gastroenterol 2020. [PMID: 33078719 DOI: 10.4103/sjg.SJG_30_20] [Reference Citation Analysis]
6 Liu Y, Li Y, Li Y, Wu S, Tian X, Tang T, Sun H, He C. Clinical Features of Intestinal Ulcers Complicated by Epstein-Barr Virus Infection: Importance of Active Infection. Dis Markers 2021;2021:6627620. [PMID: 34007344 DOI: 10.1155/2021/6627620] [Reference Citation Analysis]
7 Long Y, Zhao X, Xia C, Liu X, Fan C, Liu C. Infection of Epstein-Barr Virus is Associated with the Decrease of Helios+FoxP3+Regulatory T Cells in Active Ulcerative Colitis Patients. Immunol Invest 2021;50:23-36. [PMID: 32046542 DOI: 10.1080/08820139.2020.1723021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]